[1]
M. Foroutan, L. Zaki, S. Tavakoli, S. Soltani, A. Taghipour, and F. Ghaffarifar, “Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii”, EXCLI J., vol. 18, pp. 259–272, May 2019.